← Back to Search

Platelet-rich Plasma Therapy

Platelet-rich Plasma Therapy for Hair Loss

Phase < 1

Waitlist Available

Led By Rita Pichardo, MD

Research Sponsored by Wake Forest University Health Sciences

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Female ≥18 years of age at baseline visit.

Documentation of androgenic alopecia diagnosis as evidenced by one or more clinical features

Must not have

Have an infection, metastatic disease or certain skin conditions (ie. Psoriasis) which could worsen or spread with injections

Diagnosed with a blood or bleeding disorder

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

No Placebo-Only Group

Summary

This trial will test whether a special blood product can help treat hair loss in women.

Who is the study for?

This trial is for women over 18 with androgenic alopecia who aren't currently treating their hair loss or have stopped treatments for at least two weeks. Participants must be able to follow the study's procedures and give written consent. Women can't join if they're pregnant, breastfeeding, have anemia, are on blood thinners, have certain skin conditions like psoriasis, infections or metastatic diseases.

What is being tested?

The trial is testing platelet-rich plasma therapy on either side of the scalp to see how effective it is in treating female pattern hair loss. Platelet-rich plasma is made from a participant's own blood.

What are the potential side effects?

Potential side effects may include discomfort at injection sites, infection risk due to injections, possible worsening of existing skin conditions like psoriasis if present elsewhere on the body.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am a woman aged 18 or older.

Select...

I have been diagnosed with hair loss due to male or female pattern baldness.

Select...

I am a woman aged 18 or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I do not have infections, metastatic disease, or skin conditions like psoriasis that could worsen with injections.

Select...

I have been diagnosed with a blood or bleeding disorder.

Select...

I am currently taking blood thinners.

Select...

I have been diagnosed with anemia.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in Severity of Alopecia Tool (SALT) from baseline

Secondary study objectives

Change in Hair Count (number of hairs/0.65cm^2)

Change in Hair Density (number of hairs/cm^2)

Other study objectives

Anagen to Telogen Ratio

Change in Dermatology Life Quality Index (DLQI)

Change in Hair Diameter

+1 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: Group BExperimental Treatment1 Intervention

At the baseline visit subjects will be randomized to either group A or group B. Group B will receive PRP on right side of scalp and placebo (saline solution) on left side of scalp.

Group II: Group AExperimental Treatment1 Intervention

At the baseline visit subjects will be randomized to either group A or group B. Group A will receive PRP on left side of scalp and placebo (saline solution) on right side of scalp.

0 / 7Eligibility criteria met